CLINICAL ROLE -
Molnupiravir: What We Know So Far About Oral Antiviral COVID-19 Treatment
Molnupiravir (Lagevrio) is a potent ribonucleoside analog that blocks SARS-CoV-2 replication by acting as a competitive substrate of virally-encoded RNA-dependent RNA polymerase.
Read More